Announced Thu, 23 Jul · 13:17 IST
Solara Active Pharma Q1 FY27 PAT up 55% YoY at Rs 16.31 cr
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-8.1%1-day move
₹537.80
prior close
₹534.95
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.1-2.0-1.1-0.0-8.1-6.6————————
Up moveDown movePending
AI summary
Solara Active Pharma posted Q1 FY27 consolidated revenue from operations of Rs 381.60 cr, up 19.6% YoY from Rs 319.15 cr. PAT rose 55% YoY to Rs 16.31 cr from Rs 10.52 cr; EPS at Rs 3.52 vs Rs 2.46. Includes Rs 0.86 cr exceptional gain on new labour codes. However, accumulated losses of Rs 286.21 cr; results on going concern basis. Rights issue raised Rs 442.73 cr of Rs 449.95 cr.
Likely market impact
Positive YoY earnings growth, but going concern flag from accumulated losses and pending CRAMS-Polymer demerger may keep sentiment mixed.